Shield Therapeutics (GB:STX) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Shield Therapeutics has launched a RetailBook Offer, allowing existing UK shareholders to purchase new ordinary shares at a premium price of 3.0p per share, raising up to £1 million. This offer is available through partners like AJ Bell and Hargreaves Lansdown and can be accessed using ISAs or SIPPs. The offer closes on December 20, 2024, with no commission charged by RetailBook.
For further insights into GB:STX stock, check out TipRanks’ Stock Analysis page.
